Imagenetix Inc's ability to collect accounts receivable sequentially worsen to 3.51, indicating more challenging environment then in the third quarter 2015, but still, it is a far cry from any concerns. Imagenetix Inc's Accounts Receivable average collection period in the Jun 30 2015 quarter, has increased to 104 days, from 79 days, in the Dec 31 2014 quarter.

If we take a look into Healthcare sector 330 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2015 from 0 to 3298.

What is Receivable Turnover Ratio?
What is Imagenetix Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IAGX Receivables Turnover Ratio	(Jun 30 2015) I. Quarter	(Dec 31 2014) III. Quarter	(Sep 30 2014) II. Quarter	(Dec 31 2011) III. Quarter	(Sep 30 2011) II. Quarter
Y / Y Receivable Change	-21.21 %	-29.54 %	-35.53 %	-51.52 %	-
Y / Y Revenue Change	-56.93 %	-51.63 %	-90.31 %	-87.46 %	-19.2 %
Receivable Turnover Ratio (TTM)	3.51	4.61	4.91	7.8	11.78
IAGX's Total Ranking	# 3298	# 0	# 0	#	#
Accounts Receivable average collection period days	104	79	74	47	31
Seq. Receivable Change	14.17 %	0.25 %	3.07 %	-33.21 %	2.1 %
Seq. Revenue Change	43.17 %	60.48 %	-59.3 %	-53.94 %	60.81 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 110
Healthcare Sector	# 331
Overall Market	# 3298

Receivable Turnover Ratio Statistics
High	Average	Low
0.17	0.17	0.17
(Jun 30 2015)

IAGX Company Profile • Back to IAGX Efficiency Comparisons • Compare IAGX Receivables Turnover Ratio to its Competitors

Financial Statements
Imagenetix Inc's Accounts Receivable	$ 0 Millions	Visit IAGX's Balance sheet
Imagenetix Inc's Sales TTM	$ 1 Millions	Visit IAGX's Income Statement
Sources of IAGX's Revenues		Visit IAGX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IAGX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IAGX's Growth Rates	IAGX's Roa	IAGX's Inventory Turnover Ratio	IAGX's Dividend Comparisons
IAGX's Profitability Ratios	IAGX's Roi	IAGX's Asset Turnover Ratio	IAGX's Dividend Growth
IAGX's Valuation Ratios	IAGX's Roe	IAGX's Financial Strength Ratios	IAGX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2015, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2015	Receivable at quarter ending Jun 30 2015
Abiomed Inc	8.67	$ 254.932 Millions	$ 29.411 Millions
Idexx Laboratories Inc	8.65	$ 1,531.302 Millions	$ 177.130 Millions
American Bio Medica Corporation	8.64	$ 6.701 Millions	$ 0.776 Millions
Masimo Corp	8.61	$ 616.169 Millions	$ 71.547 Millions
United Therapeutics Corporation	8.61	$ 1,350.978 Millions	$ 156.889 Millions
Quidelortho Corp	8.60	$ 200.629 Millions	$ 23.324 Millions
Insys Therapeutics, Inc.	8.57	$ 273.196 Millions	$ 31.882 Millions
American Caresource Holdings, Inc.	8.56	$ 32.446 Millions	$ 3.792 Millions
Invo Fertility Inc	8.55	$ 0.014 Millions	$ 0.002 Millions
Star Equity Holdings Inc	8.54	$ 57.410 Millions	$ 6.724 Millions
Encompass Health Corporation	8.52	$ 2,715.300 Millions	$ 318.625 Millions
Nephros Inc	8.47	$ 1.945 Millions	$ 0.229 Millions
Prestige Consumer Healthcare Inc	8.46	$ 761.053 Millions	$ 89.943 Millions
Syneos Health Inc	8.45	$ 1,272.488 Millions	$ 150.572 Millions
Supernus Pharmaceuticals inc	8.37	$ 146.908 Millions	$ 17.559 Millions
Reflect Scientific Inc	8.36	$ 1.258 Millions	$ 0.150 Millions
Interpace Biosciences Inc	8.34	$ 127.556 Millions	$ 15.300 Millions
Utah Medical Products Inc	8.33	$ 41.590 Millions	$ 4.994 Millions
Inotiv Inc	8.29	$ 24.141 Millions	$ 2.913 Millions
Genomic Health Inc	8.28	$ 276.998 Millions	$ 33.441 Millions
Cantel Medical Corp	8.26	$ 565.004 Millions	$ 68.383 Millions
Musclepharm Corporation	8.26	$ 172.238 Millions	$ 20.858 Millions
Soligenix inc	8.26	$ 6.630 Millions	$ 0.803 Millions
Incyte Corporation	8.25	$ 644.379 Millions	$ 78.065 Millions
Elite Pharmaceuticals Inc	8.24	$ 10.933 Millions	$ 1.327 Millions
Ptc Therapeutics inc	8.15	$ 28.607 Millions	$ 3.508 Millions
Nrc Health	8.15	$ 99.540 Millions	$ 12.207 Millions
Myriad Genetics Inc	8.15	$ 723.100 Millions	$ 88.729 Millions
Durect Corp	8.15	$ 17.741 Millions	$ 2.178 Millions
Agenus Inc	8.13	$ 13.512 Millions	$ 1.661 Millions

Date modified: 2026-08-29T17:14:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.